ReviewSmart molecules : open access2025
Circularly polarized luminescence from supramolecular assemblies based on small molecules.
Review in Smart molecules : open access, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Achiral guest-mediated modulation of circularly polarized luminescence in chiral charge-transfer cocrystals.Chemical science · 2026Article
- Multivalent-Anion-Induced Inversion of Chiroptical Signals in a Cyanine Dye Bound to Nanotubular Supramolecular Assemblies.Langmuir : the ACS journal of surfaces and colloids · 2026Article
- Circularly polarized luminescence from supramolecular assemblies based on small molecules.Smart molecules : open access · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Circularly polarized luminescence (CPL)-active materials have a wide range of technological applications. Traditionally, creating CPL-active materials relies on the use of chiral luminophores. In contrast, supramolecular assembly introduces an innovative and promising strategy for developing CPL-active materials not only from chiral luminophores but also from achiral species. This approach significantly enriches the diversity of CPL-active materials. It also offers an effective means to optimize the performance of CPL-active materials, such as enhancing the asymmetry factor |
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.